ArticleNature communications2023

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis.

Julia Åkesson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.